查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552516

荷尔蒙避孕药市场，规模，占有率，趋势，产业分析报告:各产品，荷尔蒙，各流通管道，各地区- 市场预测，2024年～2032年

Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product, By Hormone, By Distribution Channel, and By Region - Market Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 126 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球荷尔蒙避孕药市场规模预计将达到 246 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于人们对计划生育和生殖健康的认识不断提高、越来越多地采用荷尔蒙避孕药作为可靠的避孕方法以及避孕技术的进步，全球荷尔蒙避孕药市场正在经历强劲增长。主要推动因素包括对妇女健康和赋权的日益重视，以及性传染感染（STI）盛行率的上升，促使政府采取支持性措施、政策和预防措施来促进避孕药具的取得。市场趋势是由长效可逆避孕药（LARC）等创新激素避孕药的转变以及对口服避孕药和激素贴剂等个性化和便捷选择的需求所推动的。

在医疗基础设施进步和经济状况改善的推动下，新兴市场的荷尔蒙避孕药市场正经历显着成长。对医疗保健系统的投资也扩大了人们获得各种避孕选择的机会，使荷尔蒙避孕药具得到更广泛的使用。财务稳定性的提高意味着更多的人能够负担得起并优先考虑计划生育服务。此外，提高生殖健康意识和教育也促进了需求的增加。各国政府和组织也致力于透过公共卫生措施和补贴来改善可及性，进一步提高可用性。这一市场扩张反映了新兴国家向更好的生殖健康选择和赋予妇女权力的积极转变。

荷尔蒙避孕药市场报告亮点

由于口服避孕药的广泛使用、已确定的功效以及长期以来消费者的熟悉度，口服避孕药仍然是一个主要领域。

纯黄体素避孕药，包括纯黄体素药丸、植入物和注射等方法，越来越受欢迎，因为它们适合不能使用雌激素或喜欢单一荷尔蒙方法的女性。

目前，零售药局在市场上占据主导地位，因为它们对消费者来说广泛且方便。

成长最快的领域是医院药局。这一增长是由于获得医疗保健的机会增加以及对临床环境中综合生殖健康服务的日益关注所推动的。

北美预计将主导市场，而亚太地区预计将呈现最高成长率。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球荷尔蒙避孕药市场洞察

  • 市场概述
  • 荷尔蒙避孕药市场动态
    • 促进因素和机会
      • 对长效可逆避孕药 (LARC) 的需求不断增长推动市场成长
      • 向个人化和便捷避孕方法的转变推动市场发展
    • 阻碍因素与课题
      • 健康上的疑虑和副作用妨碍着荷尔蒙避孕药市场成长
  • PESTEL分析
  • 荷尔蒙避孕药市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球荷尔蒙避孕药市场: 各产品

  • 主要调查结果
  • 简介
  • 锭剂
  • 皮肤贴片
  • 荷尔蒙植入物
  • 阴道环
  • 皮肤贴片
  • 其他

第6章 全球荷尔蒙避孕药市场:荷尔蒙

  • 主要调查结果
  • 简介
  • 仅含黄体素
  • 复方荷尔蒙避孕药

第7章 全球荷尔蒙避孕药市场: 各流通管道

  • 主要调查结果
  • 简介
  • 医院药局
  • 零售药局
  • 其他

第8章 全球荷尔蒙避孕药市场:各地区

  • 主要调查结果
  • 简介
    • 荷尔蒙避孕药市场评估:各地区，2019年～2032年
  • 北美
    • 北美:各产品，2019年～2032年
    • 北美:各荷尔蒙，2019年～2032年
    • 北美:各流通管道，2019年～2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2019年～2032年
    • 欧洲:荷尔蒙，2019年～2032年
    • 欧洲:各流通管道，2019年～2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2019年～2032年
    • 亚太地区:荷尔蒙，2019年～2032年
    • 亚太地区:各流通管道，2019年～2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2019年～2032年
    • 中东·非洲:荷尔蒙，2019年～2032年
    • 中东·非洲:各流通管道，2019年～2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2019年～2032年
    • 南美:荷尔蒙，2019年～2032年
    • 南美:各流通管道，2019年～2032年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • HRA Pharma
  • Mithra Pharmaceuticals
  • Celgene Corporation
  • Allergan plc
  • Procter & Gamble Co.
  • Reddy's Laboratories Ltd.
Product Code: PM2570

The global hormonal contraceptive market size is expected to reach USD 24.60 billion by 2032, according to a new study by Polaris Market Research. The report "Global Hormonal Contraceptive Market Size, Share, Trends, Industry Analysis Report: By Product (Pills, Skin Patches, Intrauterine Devices, Hormonal Implants, Vaginal Rings, and Others), By Hormone, By Distribution Channel, and By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global hormonal contraceptive market is experiencing robust growth, driven by increasing awareness about family planning and reproductive health, rising adoption of hormonal contraceptives as a reliable method of birth control, and advancements in contraceptive technology. Key drivers include the growing emphasis on women's health and empowerment, supportive government initiatives and policies promoting contraceptive access, and the rising prevalence of sexually transmitted infections (STIs), which encourages preventive measures. Trends in the market show a shift towards innovative hormonal contraceptives, such as long-acting reversible contraceptives (LARCs), and a rising demand for personalized and convenient options like oral contraceptives and hormonal patches.

The hormonal contraceptive market in emerging markets is experiencing significant growth, driven by advancements in healthcare infrastructure and improving economic conditions. Also, investment in healthcare systems, access to a variety of contraceptive options is expanding, making hormonal contraceptives more widely available. Enhanced economic stability allows more individuals to afford and prioritize family planning services. Additionally, increased awareness and education about reproductive health contribute to higher demand. Governments and organizations are also focusing on improving access through public health initiatives and subsidies, further boosting availability. This growing market reflects a positive shift towards better reproductive health options and empowerment for women in emerging economies.

Hormonal Contraceptive Market Report Highlight

Oral contraceptive pills remain the dominant segment due to their widespread use, well-established efficacy, and long-standing consumer familiarity.

Progestin-Only Contraceptives, which include methods like progestin-only pills, implants, and injections, are increasingly popular due to their suitability for women who cannot use estrogen or prefer a single-hormone approach.

Retail pharmacies currently dominate the market due to their widespread accessibility and convenience for consumers.

The highest-growing segment is hospital pharmacies. This growth is fueled by increasing healthcare access and a rising focus on comprehensive reproductive health services within clinical settings.

North America dominates the market, while Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, hormone, distribution channel and region

Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pills
  • Skin Patches
  • Intrauterine Devices
  • Hormonal Implants
  • Vaginal Rings
  • Others

Hormonal Contraceptive, Hormone Outlook (Revenue - USD Billion, 2019 - 2032)

  • Progestin Only
  • Combined Hormone Contraceptives

Hormonal Contraceptive, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hormonal Contraceptive Market Insights

  • 4.1. Hormonal Contraceptive Market - Market Snapshot
  • 4.2. Hormonal Contraceptive Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Long-Acting Reversible Contraceptives (LARCs) Is Driving the Market Growth
      • 4.2.1.2. Shift Towards Personalized and Convenient Contraceptive Options Propels the Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Health Concerns and Side Effects is hindering the Hormonal Contraceptive Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Hormonal Contraceptive Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hormonal Contraceptive Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Pills
    • 5.3.1. Global Hormonal Contraceptive Market, by Pills, by Region, 2019-2032 (USD Billion)
  • 5.4. Skin Patches
    • 5.4.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
  • 5.5. Hormonal Implants
    • 5.5.1. Global Hormonal Contraceptive Market, by Hormonal Implants, by Region, 2019-2032 (USD Billion)
  • 5.6. Vaginal Rings
    • 5.6.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2019-2032 (USD Billion)
  • 5.7. Skin Patches
    • 5.7.1. Global Hormonal Contraceptive Market, by Skin Patches, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Hormonal Contraceptive Market, by Hormone

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • 6.3. Progestin Only
    • 6.3.1. Global Hormonal Contraceptive Market, by Progestin Only, by Region, 2019-2032 (USD Billion)
  • 6.4. Combined Hormone Contraceptives
    • 6.4.1. Global Hormonal Contraceptive Market, by Combined Hormone Contraceptives, by Region, 2019-2032 (USD Billion)

7. Global Hormonal Contraceptive Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Hormonal Contraceptive Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Hormonal Contraceptive Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Hormonal Contraceptive Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Hormonal Contraceptive Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Hormonal Contraceptive Market - North America
    • 8.3.1. North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.3.3. North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Hormonal Contraceptive Market - U.S.
      • 8.3.4.1. U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Hormonal Contraceptive Market - Canada
      • 8.3.5.1. Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Hormonal Contraceptive Market - Europe
    • 8.4.1. Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Hormonal Contraceptive Market - UK
      • 8.4.4.1. UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Hormonal Contraceptive Market - France
      • 8.4.5.1. France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Hormonal Contraceptive Market - Germany
      • 8.4.6.1. Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Hormonal Contraceptive Market - Italy
      • 8.4.7.1. Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Hormonal Contraceptive Market - Spain
      • 8.4.8.1. Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Hormonal Contraceptive Market - Netherlands
      • 8.4.9.1. Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Hormonal Contraceptive Market - Russia
      • 8.4.10.1. Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.11. Hormonal Contraceptive Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.4.11.2. Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.4.11.3. Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Hormonal Contraceptive Market - Asia Pacific
    • 8.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Hormonal Contraceptive Market - China
      • 8.5.4.1. China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Hormonal Contraceptive Market - India
      • 8.5.5.1. India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Hormonal Contraceptive Market - Malaysia
      • 8.5.6.1. Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Hormonal Contraceptive Market - Japan
      • 8.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Hormonal Contraceptive Market - Indonesia
      • 8.5.8.1. Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Hormonal Contraceptive Market - South Korea
      • 8.5.9.1. South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.10. Hormonal Contraceptive Market - Australia
      • 8.5.10.1. Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.10.2. Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.10.3. Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.11. Hormonal Contraceptive Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Hormonal Contraceptive Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Hormonal Contraceptive Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Hormonal Contraceptive Market - UAE
      • 8.6.5.1. UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Hormonal Contraceptive Market - Israel
      • 8.6.6.1. Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Hormonal Contraceptive Market - South Africa
      • 8.6.7.1. South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.8. Hormonal Contraceptive Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Hormonal Contraceptive Market - Latin America
    • 8.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Hormonal Contraceptive Market - Mexico
      • 8.7.4.1. Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Hormonal Contraceptive Market - Brazil
      • 8.7.5.1. Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Hormonal Contraceptive Market - Argentina
      • 8.7.6.1. Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.7. Hormonal Contraceptive Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bayer AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Pfizer Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merck & Co., Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Johnson & Johnson
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. AbbVie Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teva Pharmaceutical Industries Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novartis AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. HRA Pharma
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mithra Pharmaceuticals
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Celgene Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Allergan plc
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Procter & Gamble Co.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Reddy's Laboratories Ltd.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables:

  • Table 1 Global Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 3 Global Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 North America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 6 North America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 U.S.: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 8 U.S.: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 9 U.S.: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 Canada: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Canada: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 12 Canada: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 14 Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 15 Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 UK: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 17 UK: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 18 UK: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 France: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 20 France: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 21 France: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Germany: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 24 Germany: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Italy: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 26 Italy: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 27 Italy: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Spain: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 29 Spain: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 30 Spain: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Netherlands: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Russia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Russia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 36 Russia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Rest of Europe: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 38 Rest of Europe: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 39 Rest of Europe: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 42 Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 44 China: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 45 China: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 47 India: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 48 India: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 50 Malaysia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 51 Malaysia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Japan: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 54 Japan: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 56 Indonesia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 57 Indonesia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 59 South Korea: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 60 South Korea: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Australia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 62 Australia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 63 Australia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Rest of Asia Pacific: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 65 Rest of Asia Pacific: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 66 Rest of Asia Pacific: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 69 Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Saudi Arabia: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 71 Saudi Arabia: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 72 Saudi Arabia: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 UAE: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 74 UAE: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 75 UAE: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Israel: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 77 Israel: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 78 Israel: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 South Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 80 South Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 81 South Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 86 Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 87 Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 88 Mexico: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 89 Mexico: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 90 Mexico: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 Brazil: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 92 Brazil: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 93 Brazil: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Argentina: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 95 Argentina: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 96 Argentina: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 97 Rest of Latin America: Hormonal Contraceptive Market, by Product, 2019-2032 (USD Billion)
  • Table 98 Rest of Latin America: Hormonal Contraceptive Market, by Hormone, 2019-2032 (USD Billion)
  • Table 99 Rest of Latin America: Hormonal Contraceptive Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures:

  • Figure 1. Global Hormonal Contraceptive Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Hormonal Contraceptive Market, by Product, 2023 & 2032 (USD Billion)
  • Figure 8. Market by Hormone
  • Figure 9. Global Hormonal Contraceptive Market, by Hormone, 2023 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Hormonal Contraceptive Market, by Distribution Channel, 2023 & 2032 (USD Billion)